Trial Profile
Bridging Therapy in Patients at High Risk for Stent Thrombosis Undergoing Surgery.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Tirofiban (Primary)
- Indications Stent thrombosis
- Focus Therapeutic Use
- 10 Sep 2009 Planned end date changed from 1 Apr 2009 to 1 Apr 2011 as reported by ClinicalTrials.gov.
- 10 Sep 2009 Status changed from active, no longer recruiting to recruiting as reported by ClinicalTrials.gov.
- 28 Apr 2008 New trial record.